coagulation factor VIII

Mentioned in ?

References in periodicals archive ?

A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Deteccion de mutaciones en el gen F8 en mujeres portadoras y en pacientes con hemofilia A. Identificacion de una mutacion nueva

Desmopressin, or 1-deamino-8-D-arginine vasopressin is a synthetic arginine vasopressin analog that increases the levels of plasma coagulation factor VIII and vWF [sup][1],[2] and improves PLT function.

Effect of Desmopressin on Platelet Aggregation and Blood Loss in Patients Undergoing Valvular Heart Surgery

The company said OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence] has been approved in Canada for the treatment of bleeding episodes in patients with acquired hemophilia A caused by autoantibodies to coagulation Factor VIII (FVIII), a very rare and life-threatening acute bleeding disorder.

Baxalta passes Health Canada's approval for OBIZUR for Acquired Hemophilia A

Contract notice: Fn motol - human coagulation factor viii.

Fn Motol - Human Coagulation Factor Viii

Coagulation factor viii (efmoroctocog alfa), Dispensing form: Injection, Strength: 250 iu, Unit value: 500 iu, Quantity in units: 10.

Supply Of Drug : Amgros

Coagulation factor viii (octocog alfa), Dispensing form: Injection, Strength: 250 iu, Unit value: 500 iu, Quantity in units: 840.

Supply Of Pharmaceutical Products

Continuous supply of octocog alfa 250 IU recombinant human coagulation factor VIII third generation - the estimated number of 960 packs.

Czech Republic-prague: Medicinal Products For The Blood And Blood-forming Organs

Contract award notice: Conclusion of a framework agreement on the selection of contractors for the delivery of human coagulation factor VIII concentrate containing von Willebrand factor for the treatment of von Willebrand disease in a proportion of at least 1 von Willebrand factor per unit of coagulation factor VIII together with the administration kit.

Conclusion Of A Framework Agreement On The Selection Of Contractors For The Delivery Of Human Coagulation Factor Viii Concentrate Containing Von Willebrand Factor For The Treatment Of Von Willebrand's Disease

Medical browser ?

Full browser ?